Impact Biomedical (IBO) Intangibles (2022 - 2026)

Impact Biomedical's Intangibles history runs 5 years deep, the most recent figure standing at $22.6 million for Q1 2026.

• Quarterly Intangibles rose 26.51% year-over-year to $22.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.6 million (up 26.51% YoY) and the FY2025 annual result came in at $17.0 million, down 23.66% from the prior year.
• Intangibles was $22.6 million for Q1 2026 at Impact Biomedical, up from $17.0 million in the prior quarter.
• Across five years, Intangibles topped out at $22.6 million in Q1 2026 and bottomed at $17.0 million in Q4 2025.
• A 5-year average of $19.3 million and a median of $18.6 million in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2025 — Intangibles retreated 23.66% — and 2026, when it grew 26.51%.
• Impact Biomedical's Intangibles stood at $20.0 million in 2022, then fell by 5.56% to $18.9 million in 2023, then gained by 17.65% to $22.3 million in 2024, then slipped by 23.66% to $17.0 million in 2025, then jumped by 32.9% to $22.6 million in 2026.
• Business Quant data shows IBO's Intangibles at $22.6 million in Q1 2026, $17.0 million in Q4 2025, and $17.3 million in Q3 2025.